Literature DB >> 11745740

Tissue distribution of terbinafine in rats.

M Hosseini-Yeganeh1, A J McLachlan.   

Abstract

Terbinafine is an allylamine antifungal agent that is highly lipophilic and keratophilic. The aim of this study was to investigate terbinafine distribution in peripheral and visceral tissues after intravenous administration to rats. Terbinafine, 6 mg/kg, was administered to 33 male Sprague-Dawley rats via a jugular vein cannula over 30 s. Groups of 3 rats were sacrificed at each of 11 time points (up to 24 h), and plasma and tissues were dissected, sampled, and analyzed by high-performance liquid chromatography. Terbinafine plasma concentrations declined in a triexponential fashion, with an estimated elimination half-life of 10 h. The estimated clearance of terbinafine in rats was 2 L/h/kg and the volume of distribution at steady state was 6 L/kg. The tissue-to-plasma partition coefficient (K(p)) of terbinafine for different tissues was calculated using the ratio of the area under the curve of concentration-time for tissues (AUC(tissue)) to that for plasma (AUC(plasma)), by parametric and semiparametric approaches. There was good agreement between K(p) estimates determined by different approaches. The preferential distribution of terbinafine to adipose and skin (K(p) = 49 and 45, respectively) was consistent with the lipophilicity of the drug. Uptake of terbinafine into brain (K(p) = 1.3) and muscle (K(p) = 1.0) was significantly lower. In conclusion, terbinafine displays extensive uptake to peripheral tissues, which contributes to the long elimination half-life of this drug. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745740     DOI: 10.1002/jps.1132

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

Review 1.  Human pharmacogenomic variations and their implications for antifungal efficacy.

Authors:  Joseph Meletiadis; Stephen Chanock; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  A recursive-partitioning model for blood-brain barrier permeation.

Authors:  S R Mente; F Lombardo
Journal:  J Comput Aided Mol Des       Date:  2005-12-06       Impact factor: 3.686

3.  Physiologically based pharmacokinetic model for terbinafine in rats and humans.

Authors:  Mahboubeh Hosseini-Yeganeh; Andrew J McLachlan
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

4.  In vitro investigation of a terbinafine impregnated subcutaneous implant for veterinary use.

Authors:  M J Souza; T Cairns; J Yarbrogh; S K Cox
Journal:  J Drug Deliv       Date:  2012-07-19

5.  Development of terbinafine solid lipid nanoparticles as a topical delivery system.

Authors:  Ying-Chen Chen; Der-Zen Liu; Jun-Jen Liu; Tsung-Wei Chang; Hsiu-O Ho; Ming-Thau Sheu
Journal:  Int J Nanomedicine       Date:  2012-08-15

Review 6.  Clinical Relevance and Characteristics of Aspergillus calidoustus and Other Aspergillus Species of Section Usti.

Authors:  Emmanouil Glampedakis; Véronique Erard; Frederic Lamoth
Journal:  J Fungi (Basel)       Date:  2020-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.